Opioidergic modulation of ventilatory response to sustained hypoxia in obese Zucker rats

Citation
Sd. Lee et al., Opioidergic modulation of ventilatory response to sustained hypoxia in obese Zucker rats, OBES RES, 9(7), 2001, pp. 407-413
Citations number
28
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
OBESITY RESEARCH
ISSN journal
10717323 → ACNP
Volume
9
Issue
7
Year of publication
2001
Pages
407 - 413
Database
ISI
SICI code
1071-7323(200107)9:7<407:OMOVRT>2.0.ZU;2-N
Abstract
Objective: To determine whether altered central and/or peripheral opioiderg ic mechanisms contribute to the altered ventilatory response to sustained h ypoxia in obese Zucker rats. Research Methods and Procedures: Eight lean (176 +/- 8 [SEM] g) and eight o bese (225 +/- 12 g) Zucker rats were studied at 6 weeks of age. Pulmonary V entilation (V(over dot)(E)) tidal volume (V-T), and breathing frequency (f) at rest and in response to sustained (30 minutes) hypoxic (10% O-2) challe nges were measured on three separate occasions by the barometric method aft er the randomized, blinded administration of equal volumes of saline (contr ol), naloxone methiodide (N-M; 5 mg/kg, peripheral opioid antagonist), or n aloxone hydrochloride (N-HCl; 5 mg/kg, peripheral and central opioid antago nist). Results: Administration of N-M and N-HCl in lean animals had no effect on V (over dot)(E) either at rest or during 30 minutes of sustained exposure to hypoxia. Similarly, N-M failed to alter V(over dot)(E) in obese rats. In co ntrast, N-HCl significantly (p < 0.05) increased V(over dot)(E), and V-T bo th at rest and during 2 to 10 minutes of hypoxic exposure in obese rats. Af ter 20 to 30 minutes of hypoxic exposure, V-T remained elevated with N-HCl, but the earlier elevation of V(over dot)(E) seemed to be attenuated due to a decrease in f at 20 minutes of exposure to hypoxia. Discussion: Thus, endogenous opioids modulate both resting V(over dot)(E) a nd the ventilatory response to sustained hypoxia in obese, but not in lean, Zucker rats by acting specifically on opioid receptors located within the central nervous system.